Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2013

View Archived Issues

Inflection Biosciences and CNIO present novel dual PIM/PI3K and triple PIM/PI3K/mTOR inhibitors

Oxygen Biotherapeutics closes acquisition of Phyxius Pharma's levosimendan

UCI-50027 as a promising neuroactive steroid showing anticonvulsant and anxiolytic activity in vivo

Roche reports on discovery of a novel, direct-acting, RNA polymerase enzyme inhibitor to target HCV

Xofigo obtains marketing authorization in the E.U.

Ajinomoto patents novel integrin alpha4beta7 receptor antagonists

Toray Industries divulges novel soluble epoxide hydrolase inhibitors

Toyama Chemical scientists prepare and test deuterated antiviral agents

Yale University reports discovery of cytotoxic-drug-delivering molecules for HIV

Trk-A inhibitors reported in Ono Pharmaceutical patent

Global Genomics and Metabolon partner to discover cardiovascular disease biomarkers and drug targets

Cepheid presents early data for Xpert HPV test

FDA grants orphan drug designation to Epidiolex for Dravet syndrome

Baxter and Cell Therapeutics enter licensing agreement for pacritinib

ChanRx presents promising data from the COR-ART phase II trial

French ATU granted for Vimizim in Morquio A syndrome

Eisai forms partnership to make Halaven available in the Middle East

A novel KIT gene mutation identified in papillary thyroid carcinoma

Sanofi discontinues development of fedratinib over safety concerns

Akorn acquires U.S. rights to three ophthalmic products from Merck & Co.

BARDA exercises option for continued development of AverTox against nerve agents

FDA approves Valeant's Luzu for three fungal indications

Bayer, Inception Sciences and Versant Ventures establish ophthalmology collaboration

Tolerability and immunogenicity of the live attenuated tetravalent dengue vaccine candidate TV-003

Phase Ib trial for ATU-027 planned in head and neck squamous cell carcinoma

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...